Special Drug Use Results Survey of Targretin capsules 75-mg in patients with Cutaneous T-cell Lymphomas
Not Applicable
- Conditions
- Cutaneous T-Cell Lymphomas
- Registration Number
- JPRN-UMIN000022568
- Lead Sponsor
- Minophagen Pharmaceutical Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
No criteria
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety, Efficacy
- Secondary Outcome Measures
Name Time Method